B

Biohit Oyj
OMXH:BIOBV

Watchlist Manager
Biohit Oyj
OMXH:BIOBV
Watchlist
Price: 2.39 EUR 1.7%
Market Cap: 36.1m EUR
Have any thoughts about
Biohit Oyj?
Write Note

Biohit Oyj
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biohit Oyj
Cash Equivalents Peer Comparison

Comparables:
R
REG1V
M
MODU
B
BRETEC
O
OPTOMED
N
NXTMH

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
B
Biohit Oyj
OMXH:BIOBV
Cash Equivalents
€1.8m
CAGR 3-Years
22%
CAGR 5-Years
7%
CAGR 10-Years
20%
R
Revenio Group Oyj
OMXH:REG1V
Cash Equivalents
€21.5m
CAGR 3-Years
-9%
CAGR 5-Years
16%
CAGR 10-Years
17%
M
Modulight Oyj
OMXH:MODU
Cash Equivalents
€409k
CAGR 3-Years
-39%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
B
Bioretec Oy
OMXH:BRETEC
Cash Equivalents
€6.9m
CAGR 3-Years
45%
CAGR 5-Years
41%
CAGR 10-Years
N/A
O
Optomed Oyj
OMXH:OPTOMED
Cash Equivalents
€7.1m
CAGR 3-Years
-12%
CAGR 5-Years
29%
CAGR 10-Years
N/A
N
Nexstim Oyj
OMXH:NXTMH
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biohit Oyj's Cash Equivalents?
Cash Equivalents
1.8m EUR

Based on the financial report for Jun 30, 2024, Biohit Oyj's Cash Equivalents amounts to 1.8m EUR.

What is Biohit Oyj's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
20%

Over the last year, the Cash Equivalents growth was 6%. The average annual Cash Equivalents growth rates for Biohit Oyj have been 22% over the past three years , 7% over the past five years , and 20% over the past ten years .

Back to Top